What parents should know about Pfizer shot for kids
Dr. Jon LaPook explains how parents should determine whether their children should get Pfizer's COVID-19 vaccine and how soon they can get it.
Food and Drug Administration
A third of people in the U.S. are fully vaccinated
A third of the U.S. population is now fully vaccinated against the coronavirus. But the pace of inoculations is slowing, forcing public health officials to shift their approach. As Janet Shamlian shows us, there are new efforts to expand vaccine access and eligibility. Then, pediatrician Dr. Suzette Oyeku from the Children’s Hospital at Montefiore joins CBSN's Lana Zak with her analysis.
Pfizer seeks full approval for COVID vaccine
Pfizer has announced that it is officially seeking full Food and Drug Administration approval for its coronavirus vaccine, the first of the three U.S.-approved COVID vaccines being administered under emergency authorization. This as new infections appear to be on the decline, as is demand for vaccines. CBS News correspondent Laura Podesta joins CBSN AM to discuss.
Gottlieb calls for easing restrictions on indoor gatherings
Dr. Scott Gottlieb, the former FDA commissioner, says many areas of the U.S. are "at a point in time where we can start to lift these [COVID-19] ordinances."
Transcript: Scott Gottlieb on "Face the Nation"
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired May 9, 2021, on "Face the Nation."
FDA to greenlight COVID shot for adolescents
The number of Americans getting vaccinated is dropping off. But two upcoming decisions from the Food and Drug Administration could provide a possible turnaround and give the nation a much-needed shot in the arm. Michael George reports from a vaccination site in New York.
Pfizer asks FDA for full approval of COVID vaccine
Pfizer is asking the Food and Drug Administration for full approval of its vaccine for people 16 and older. Janet Shamlian has more.
Pfizer seeks full FDA approval for COVID vaccine
Pfizer and BioNTech have formally begun the application process to get full approval for their COVID-19 vaccine from the Food and Drug Administration. It would be the first coronavirus vaccine in the U.S. to move past the emergency use stage. Dr. Bob Lahita, director of the Institute for Autoimmune and Rheumatic Diseases at St. Joseph Health, joined CBSN to discuss this and other developments in the fight against the pandemic.
Vaccine access could soon expand to kids
The CDC Advisory Committee on Immunization Practices will hold an emergency meeting next week, as Pfizer prepares to seek authorization to offer its vaccine for kids age 12 to 15. Internal medicine specialist and immunologist Dr. Neeta Ogden joins CBSN to discuss that, plus efforts to develop future vaccines that could come in the form of a patch or a pill.
FDA expected to approve vaccine for adolescents
The FDA could soon approve its first coronavirus vaccine for kids as young as 12 years old. As CBS News' Mola Lenghi reports, children now make up nearly a fourth all new cases in the U.S. Then Dr. Payal Patel, an infectious diseases physician at the University of Michigan Medical School, joins CBSN's Elaine Quijano to discuss the latest COVID headlines.
Pfizer seeking vaccine authorization for adolescents
The FDA is expected to authorize Pfizer-BioNTech's COVID-19 vaccine for administration to adolescents by early next week. The company is also preparing to seek full FDA approval — not just emergency authorization — for adults. Mola Lenghi reports.
FDA may allow Pfizer vaccine for adolescents
The Food and Drug Administration is expected to expand the authorization for Pfizer's coronavirus vaccine to children ages 12 to 15 in the coming days. The CDC's Advisory Committee on Vaccination Practices would also need to update its recommendations for the shot. Dr. Dyan Hes, founder of Gramercy Pediatrics in New York City, joined CBSN to discuss the next steps in the vaccination effort.
FDA expected to approve vaccine for some kids
The FDA is expected to approve Pfizer's vaccine for children aged 12 to 15 year old as early as the end of this week. This comes as New York, Connecticut and New Jersey all announced they would lift most capacity limits on May 19. Mola Lenghi reports.
Gottlieb says U.S. "locking in" gains against COVID-19 as vaccinations continue
Dr. Scott Gottlieb, the former FDA commissioner, says the nationwide effort to vaccinate Americans has been a "monumental achievement."
Transcript: Scott Gottlieb on "Face the Nation"
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired May 2, 2021, on "Face the Nation."
Biden intends to ban menthol cigarettes and flavored cigars
The administration announced the ban Thursday, but it won't take effect immediately.
FDA to ban menthol cigarettes, some cigars
The Food and Drug Administration said it will ban menthol cigarettes and flavored cigars, but it was unclear when the ban will go into effect. The federal agency was ordered by a court to respond to a 2013 petition advocating for the ban. Tanya Rivero has more.
FDA lifts pause on J&J vaccine amid growing hesitancy
The FDA has lifted the temporary pause of Johnson & Johnson's coronavirus vaccine and states will now distribute the doses. The short pause has made many Americans much more hesitant to get the vaccine. CBS News medical contributor Dr. David Agus has the latest.
Johnson & Johnson vaccine to resume distribution
The CDC is lifting its pause on Johnson & Johnson vaccines after a nearly 10-day pause due to concerns about blood clots. New vaccines will come with an FDA warning. Johns Hopkins International Vaccine Access Center executive director Dr. Bill Moss joins CBSN to discuss the vaccine.
Transcript: Scott Gottlieb on "Face the Nation"
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired April 25, 2021, on "Face the Nation."
Johnson and Johnson vaccine back in production
Johnson and Johnson has resumed production of its coronavirus vaccine after the CDC and FDA lifted a pause to review safety issues. The vaccines will now come with a warning about the potential risk of rare, but dangerous blood clots. Danya Bacchus reports.
CDC panel recommends resuming J&J vaccine
A CDC panel recommended Friday to end the pause on the Johnson & Johnson vaccine. But the shot will come with a warning about the potential risk of rare, but dangerous, blood clots. Nikki Battiste has the details.
U.S. lifts pause on J&J vaccine
Federal health officials have given the green light to resume use of Johnson and Johnson's coronavirus vaccine. A CDC panel recommended Friday to resume using the vaccine, more than a week after it was put on pause over reports of blood clots. As Nikki Battiste reports, the vaccine will now come with a warning for some women. Dr. Payal Patel, an infectious diseases physician at the Universy of Michigan's Medical School, joined CBSN's Lana Zak to discuss the decision.
What the new J&J vaccine warning means for women
Dr. Jon LaPook explains why the new warning with the Johnson and Johnson vaccine is primarily for women under the age of 50.
CDC and FDA leaning toward resuming J&J vaccine, sources say
A decision is expected Friday, more than a week after the vaccine's distribution was paused following reports of rare but dangerous blood clots in eight people under the age of 50.
Interactive
These documents tell the story of the Cornell rape allegations
Hurricane Isaias now a Category 3 storm as it threatens northern Gulf Coast
Trump promised to lower prices for Americans. Here's what the data shows.
Pentagon's plan to livestream execution sparks intense backlash
Live
Iran's Houthi allies step up deadly attacks on Saudi Arabia
NYPD body camera footage shows aftermath of ICE agent shooting
Trump creates committee to investigate Fed's Lisa Cook
Nobel Peace Prize awarded to former ICC judge Navanethem "Navi" Pillay
Exclusive